Lv6
2510 积分 2024-04-09 加入
Design of cathepsin-sensitive linkers for tumor-selective bioconjugate drug delivery
9小时前
待确认
A Cathepsin B-Cleavable Self-Immolative Linker for the Delivery of Hydroxyl-Containing Payloads in Antibody-Drug Conjugates
12小时前
待确认
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
4天前
已完结
Impact of enzymatic reduction on bivalent bispecific antibody fragmentation and loss of product purity upon reoxidation
13天前
已完结
Investigation of antibody disulfide reduction and re-oxidation and impact to biological activities
13天前
已完结
Preclinical activity for TPX-4589 (LM-302), an antibody-drug conjugate targeting tight junction protein CLDN18.2 in solid tumors
27天前
已完结
Reaction of sugar oxazolines with primary amines
1个月前
已完结
Strategies for high‐concentration drug substance manufacturing to facilitate subcutaneous administration: A review
1个月前
已完结
Design, synthesis and evaluation of novel, potent DNA alkylating agents and their antibody-drug conjugates (ADCs)
1个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1个月前
已完结
皖公网安备34019202002308
